Latest revision as of 14:49, 24 November 2016

Manchester iGEM 2016

H
U
M
A
N

P
R
A
C
T
I
C
E
S

˅ Timeline ˅

Hi everyone!! This is the page for our Human Practices that we have done throughout the summer. Aligned with the requirement for iGEM competition, We were always approaching different society and company to get them in recognising our project and aiming to get suggestion or critism on our project. This allowed us to have a clearer picture in the point of view of the public. We categorised each of the activities that we have to 4 different groups. - Charities, Industries, Outreach and Interview. Click on one of the 4 wheels below to find out more!

Charities

Industries

Outreach

Professional Bodies

03

March

16

23

25

July

26

27

28

25

04

August

04

10

11

13

17

19

02

September

09

20

23

03

October

Timeline

Before we launched our project, we conducted an online survey to find out the global trend of alcohol consumption and to see if our project would create an impact in the society. Overall, this survey reflected that our device would help people measure and keep track of their alcohol intake. .

@@ Line 104: / Line 104: @@
      width: 80%;
 }
+.nav80{
+    float: right;
+    width: 80%;
+}
 .titlemobile{
@@ Line 242: / Line 248: @@
 <div class="datebox">
-<div class="date1" style="position:absolute;left:57.8%; top: 850px;">16</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 850px;">03</div>
 <div class="date2" style="position:absolute;left:65.2%; top: 850px;">March</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 1050px;">23</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 1120px;">16</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 1250px;">25</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 1390px;">23</div>
-<div class="date2" style="position:absolute;left:65.2%; top: 1250px;">July</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 1660px;">25</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 1450px;">26</div>
+<div class="date2" style="position:absolute;left:65.2%; top: 1660px;">July</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 1650px;">27</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 1930px;">26</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 1850px;">27</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 2200px;">27</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 2050px;">28</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 2470px;">27</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 2250px;">28</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 2740px;">28</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 2450px;">28</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 3010px;">28</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 2650px;">28</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 3280px;">28</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 2850px;">04</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 3550px;">25</div>
-<div class="date2" style="position:absolute;left:65.2%; top: 2850px;">August</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 3820px;">04</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 3050px;">04</div>
+<div class="date2" style="position:absolute;left:65.2%; top: 3820px;">August</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 3250px;">10</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 4090px;">04</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 3450px;">11</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 4360px;">10</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 3650px;">13</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 4630px;">11</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 3850px;">17</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 4900px;">13</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 4050px;">19</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 5170px;">17</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 4250px;">02</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 5440px;">19</div>
-<div class="date2" style="position:absolute;left:65.2%; top: 4250px;">September</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 5710px;">02</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 4450px;">09</div>
+<div class="date2" style="position:absolute;left:65.2%; top: 5710px;">September</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 4650px;">20</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 5980px;">09</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 4850px;">23</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 6250px;">20</div>
-<div class="date1" style="position:absolute;left:57.8%; top: 5050px;">03</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 6520px;">23</div>
-<div class="date2" style="position:absolute;left:65.2%; top: 5050px;">October</div>
+<div class="date1" style="position:absolute;left:57.8%; top: 6790px;">03</div>
+<div class="date2" style="position:absolute;left:65.2%; top: 6790px;">October</div>
@@ Line 285: / Line 291: @@
 <div class="timelinediv"><h1>Timeline</h1></div>
-<div style="width: 100%; height: 200px;">
+<div style="width: 100%; height: 270px;">
+<div class="survey sup">
+<img class="cog0" src="https://static.igem.org/mediawiki/2016/3/32/T--Manchester--cogwheelgreen.png"></img>
+</div>
+<div class="surveyinfo">
+Before we launched our project, we conducted an online survey to find out the global trend of alcohol consumption and to see if our project would create an impact in the society.  Overall, this survey reflected that our device would help people measure and keep track of their alcohol intake.
+</a>.
+<br /><br />
+<div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach"> More information </a></div>
+</div>
+</div>
+<div style="width: 100%; height: 270px;">
 <div class="britscweek sup">
@@ Line 293: / Line 315: @@
 <div class="britscweekinfo">
-This was the team’s first outreach event! We set up a stall during British Science Week hosted by Manchester (The City of Science 2016). We taught school children different methods of chemical production and asked them their own views on the matter.
+This was the team’s first outreach event! We introduced the concept of using synthetic biology in chemical production to pupils and asked for their opinions on the matter.  The general feedback led us to believe that our AlcoPatch may have the potential of being accepted by the public despite having to <a href="https://2016.igem.org/Team:Manchester/Description">genetically modify bacteria</a>.
 <br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach"> More information </a></div>
@@ Line 299: / Line 321: @@
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="microbio sup">
 <img class="cog2" src="https://static.igem.org/mediawiki/2016/3/32/T--Manchester--cogwheelgreen.png"><img>
@@ Line 306: / Line 328: @@
 <div class="microbioinfo">
-At the AGM, we presented the preliminary research we had done into our project. We aimed to get feedback and to test what the experts thought of our idea and whether our product would gain interest from the public.
+At the Microbiology Society’s annual general conference, we presented the preliminary research we had done into our project. We received feedback from the scientific community on how we can improve the <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach">concept design</a> of our product, which then led to the development of our <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach">pilot study</a>.
 <br /><br />
 <div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach"> More information </a></div>
@@ Line 312: / Line 334: @@
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="aacademy sup">
 <img class="cog3" src="https://static.igem.org/mediawiki/2016/b/b1/T--Manchester--cogwheelblue.png"></img>
@@ Line 319: / Line 341: @@
 <div class="aacademyinfo">
-We had a skype interview with the Alcohol Academy Director, James Morris. He informed us more about the charity. We discussed in depth the Alcopatch with regards to the charity’s members and users.
+We had a Skype interview with James Morris, the director of Alcohol Academy. He thought that our AlcoPatch would be useful for <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies">health professionals</a>, specifically in furthering alcohol brief interventions.
 <br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Charities"> More information </a></div>
@@ Line 325: / Line 347: @@
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="fredsense sup">
 <img class="cog4" src="https://static.igem.org/mediawiki/2016/7/71/T--Manchester--cogwheelorange.png"><img>
@@ Line 332: / Line 354: @@
 <div class="fredsenseinfo">
-The team discussed our project with the Fredsense CEO, David Lloyd. Fredsense is a biosensor company using microorganisms to test water samples. We discussed a range of topics from the public image of biosensors to the applications and implications our Alcopatch could have.
+We spoke to Mr.David Lloyd, the CEO of a Canada-based biosensor company, FREDsense.  While he thought that our AlcoPatch might be useful for reducing <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies">drink driving</a>, he raised concerns about the <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies">public acceptance</a> of our genetically modified organism (GMO)-based product. The <a href="https://2016.igem.org/Team:Manchester/Description/mechanism1">Cell-free Mechanism</a>, however, may be more acceptable by the public as it does not involve living GMO.
 <br /><br />
 <div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Industries"> More information </a></div>
@@ Line 338: / Line 360: @@
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="esof sup">
 <img class="cog5" src="https://static.igem.org/mediawiki/2016/3/32/T--Manchester--cogwheelgreen.png"><img>
@@ Line 345: / Line 367: @@
 <div class="esofinfo">
-Our team had a stand at the Euroscience Open Forum where we discussed our project thus far. During the day we gained interest from global researchers and deliberated the experience of working in a multi-disciplinary team.
+We presented our poster at the forum and gained interest from global researchers.  From our discussions, we realised that we had difficulties communicating efficiently to the public, especially on topics beyond our individual area of expertise. So in order for us to understand one another better in this multidisciplinary <a href="https://2016.igem.org/Team:Manchester/Team">team</a>, we took part in a <a href="https://2016.igem.org/Team:Manchester/Model">ensemble modelling</a> crash course conducted by one of our modellers!
 <br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach"> More information </a></div>
@@ Line 351: / Line 373: @@
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="men sup">
 <img class="cog6" src="https://static.igem.org/mediawiki/2016/3/32/T--Manchester--cogwheelgreen.png"><img>
@@ Line 358: / Line 380: @@
 <div class="meninfo">
-Having spoken on the phone to MEN, they were very interested in implications of our Alcopatch and decided to publish an article about our project twice in their paper!
+Having spoken on the phone to the Manchester Evening News, they were very interested in the implications of our AlcoPatch. They decided to publish <a href="http://www.manchestereveningnews.co.uk/news/greater-manchester-news/manchester-university-alcohol-sweat-patch-11668573">articles</a> about our project in their paper - <a href="http://www.manchestereveningnews.co.uk/news/greater-manchester-news/young-scientists-developing-patch-measures-11699047">twice</a>!
 <br /><br />
 <div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach"> More information </a></div>
@@ Line 364: / Line 386: @@
 </div>
-<div style="width: 100%; height:200px">
+<div style="width: 100%; height:270px">
 <div class="ads sup">
 <img class="cog7" src="https://static.igem.org/mediawiki/2016/b/b1/T--Manchester--cogwheelblue.png"><img>
 </div>
 <div class="adsinfo1">
-We presented our project to representative from the charity. After which we asked them questions about our project to gain criticism and guidance to further develop our insight into the role our Alcopatch could play in society.
+We had a discussion with the representatives of this charity to find out if our AlcoPatch would benefit their members. They suggested that our product would be more effective at raising awareness of alcohol consumption rather than preventing it.  They proposed that the <a href="https://2016.igem.org/Team:Manchester/Description/mechanism1">Cell-free Mechanism</a> would be more practical as it may have longer shelf life, <a href="https://2016.igem.org/Team:Manchester/Description/mechanism1">cheaper production costs</a> and only use substances extracted from GMOs.
 <br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Charities"> More information </a></div>
@@ Line 378: / Line 400: @@
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="ibcarb sup">
 <img class="cog8" src="https://static.igem.org/mediawiki/2016/7/71/T--Manchester--cogwheelorange.png"><img>
@@ Line 384: / Line 406: @@
 <div class="ibcarbinfo">
-We spoke with Dr Doherty a representative from IB Carb, a networking agency for glyco-scientists.  We shared our projects and discussed a series of implications as well as possible funding to get us to the Jamboree!
+We pitched our project to Dr. Doherty, the Manager of IBCarb, a networking agency for glyco-scientists. After further talks with IBCarb, we managed to secure the funding for our <a href="https://2016.igem.org/Team:Manchester/Description">project</a> - one step closer to the Giant Jamboree!
 <br /><br />
 <div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Industries"> More information </a></div>
 </div>
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="experiment sup">
 <img class="cog9" src="https://static.igem.org/mediawiki/2016/3/32/T--Manchester--cogwheelgreen.png"><img>
@@ Line 395: / Line 417: @@
 <div class="experimentinfo">
-We set up a crowdfunding page on a website called the 'experiment' dot com, here we reached out to our friends and family to contribute funds towards our goal of £3000. We created a video explaining our intentions as well as uploading detailed information regarding our project.
+We set up a crowdfunding page on <a href="https://experiment.com/projects/alcopatch-a-new-way-of-detecting-alcohol-intoxication">experiment.com</a>. Here we reached out to our friends and family, introducing our AlcoPatch and asking them to contribute towards our £3000 goal. We also created a <a href="https://www.youtube.com/watch?v=bOEyz6NDHfY">video</a> which complemented the information we uploaded regarding our project.
 <br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach"> More information </a></div>
 </div>
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="heartfm sup">
 <img class="cog10" src="https://static.igem.org/mediawiki/2016/3/32/T--Manchester--cogwheelgreen.png"><img>
@@ Line 406: / Line 428: @@
 <div class="heartfminfo">
-After raising awareness of our product with Manchester Evening News, Heart FM heard about our project and asked us to talk about it on their national radio show!
+After publicising the AlcoPatch through <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach">Manchester Evening News</a>, Heart FM heard about our project and invited us to speak on their national radio show!
 <br /><br />
 <div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach"> More information </a></div>
@@ Line 413: / Line 435: @@
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="aanonymous sup">
 <img class="cog11" src="https://static.igem.org/mediawiki/2016/b/b1/T--Manchester--cogwheelblue.png"><img>
@@ Line 419: / Line 441: @@
 <div class="aanonymousinfo">
-Having attended an Alcoholics Anonymous meeting we discussed opinions and gained insight into the issues of alcoholism and possible limitations our patch would have within their organisation and with regards to alcoholism.
+We attended an Alcoholics Anonymous meeting where we facilitated a discussion about excessive drinking. After that discussion, we gained insight into the motivations behind excessive drinking, which later influenced our approach towards advertising the AlcoPatch.
 <br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Charities"> More information </a></div>
@@ Line 425: / Line 447: @@
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="npronet sup">
 <img class="cog12" src="https://static.igem.org/mediawiki/2016/7/71/T--Manchester--cogwheelorange.png"></img>
@@ Line 431: / Line 453: @@
 <div class="npronetinfo">
-We spoke to Ms Shepard from Npronet (another networking agency) about our project and asked for her own opinion of the Alcopatch.
+We spoke to Sarah Shepherd, the Network Manager of NPRONET, which is a funded network in biotechnology and bioenergy. We reviewed our project and she highlighted the importance of starting the <a href="https://2016.igem.org/Team:Manchester/Description">wet lab work</a> early, in order to complete our project on time.
 <br /><br />
 <div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Industries"> More information </a></div>
@@ Line 437: / Line 459: @@
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="mancenterprise sup">
 <img class="cog13" src="https://static.igem.org/mediawiki/2016/7/71/T--Manchester--cogwheelorange.png"><img>
@@ Line 443: / Line 465: @@
 <div class="mancenterpriseinfo">
-We gained more insight from industry specialist about our product, who gave us positive feedback and a few pointers.
+We spoke to Lynn Sheppard (Director) and Dr. Henery (Enterprise Academic Lecturer)  of Manchester Enterprise Centre. They educated us in the potential business aspect of our project. They also gave us a few pointers on the entrepreneurship that is needed to produce our AlcoPatch in a real-world context. This led our team to model the <a href="https://2016.igem.org/Team:Manchester/Model">cost effectiveness</a> of our proposed prototype.</br></br>
-<br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Industries"> More information </a></div>
 </div>
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="biopronet sup">
 <img class="cog14" src="https://static.igem.org/mediawiki/2016/7/71/T--Manchester--cogwheelorange.png"><img>
@@ Line 455: / Line 476: @@
 <div class="biopronetinfo">
-We deliberated our project with Ms Flannelly and Mr Dickinson from BioProNet. This allowed us to gain more views about our project from scientists within the molecular biology field.
+We deliberated our project with Dr. Flannelly (Network Manager) and Prof. Dickinson (Co-Director) from BioProNet, a network in the field of bioprocessing and biologics . They agreed with how the AlcoPatch would be useful to <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach">students</a> like us. However, they raised concerns with the usage of mildly <a href="https://2016.igem.org/Team:Manchester/Safety">carcinogeneic</a> ABTS dye in our <a href="https://2016.igem.org/Team:Manchester/Description/mechanism1">Cell-free Mechanism</a>. It was suggested that we find suitable alternatives to reduce risks to our potential consumers.
 <br /><br />
 <div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Industries"> More information </a></div>
@@ Line 461: / Line 482: @@
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="gmp sup">
 <img class="cog15" src="https://static.igem.org/mediawiki/2016/9/9e/T--Manchester--cogwheelyellow.png"><img>
@@ Line 467: / Line 488: @@
 <div class="gmpinfo">
-We met up with a local P.C.S.O. in the area and asked them for their personal opinion on how our patch might be of use to the greater Manchester police. They also gave us some insightful knowledge into the current practise for breathalysing as well as it's limitations.
+We spoke to a local Police Community Support Officer in the area. We asked them for their opinion on how our patch might be of use to the Greater Manchester police force. They gave us some insightful knowledge into the use of breathalysers as well as its limitations with comparison to the potentials of our AlcoPatch.
 <br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies"> More information </a></div>
@@ Line 473: / Line 494: @@
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="ukmeetup sup">
-<h4 style="position:absolute; top: 35px; left:38px; text-weight:bold;">UKMeetup</h4>
+<h4 style="position:absolute; top: 35px; left:38px; text-weight:bold;">UK Meetup</h4>
 <img class="cog16" src="https://static.igem.org/mediawiki/2016/3/32/T--Manchester--cogwheelgreen.png"></img>
 </div>
 <div class="ukmeetupinfo">
-This was the team’s chance to meet other like-minded students and share our project and the experiences we have had during the summer. As well as talking to students we talked to postgraduates concerned with the societal impacts of our project.
+This was the team’s chance to meet other like-minded students and share our project experiences we have had during the summer. We gained valuable feedback from other iGEM teams as well as discussing our project with <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach">researchers</a>. We also discussed about the societal impacts of scientific research regarding our project.
 <br /><br />
 <div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach"> More information </a></div>
@@ Line 486: / Line 507: @@
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="nhs sup">
 <img class="cog17" src="https://static.igem.org/mediawiki/2016/9/9e/T--Manchester--cogwheelyellow.png"><img>
@@ Line 492: / Line 513: @@
 <div class="nhsinfo">
-A representative from our team talked with Kelly O’Brien who is the Head of Department for Drug Support for Children. Having talked over the phone, she gave us insightful knowledge and feedback on our project.
+We had a discussion with Kelly O’Brien, the Head of Department for Drug Support for Children. She gave us insightful knowledge and feedback on our project relevance to patients with an array of alcohol-related issues. She explained that our AlcoPatch would not be beneficial to patients with <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Charities"> alcoholism</a> issue. However, if a prototype were to be made, disseminating the AlcoPatch to the public would enable us to gauge its effectiveness in educating the public on their intoxication levels.
 <br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies"> More information </a></div>
@@ Line 499: / Line 520: @@
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="ward sup">
 <img class="cog18" src="https://static.igem.org/mediawiki/2016/9/9e/T--Manchester--cogwheelyellow.png"><img>
@@ Line 505: / Line 526: @@
 <div class="wardinfo">
-We met with Andrea Vero and an IP lawyer to discuss how to protect the research of our project,  as well as the potential for patenting our Alcopatch in the future. Ward Hadaway put us in  contact with a patent attorney from Venner Shipley.
+We interviewed Andrea Vero, an intellectual property (IP) lawyer from Ward Hadaway law firm, to discuss how to protect our IP rights for the AlcoPatch. We also discussed the potential for patenting our AlcoPatch in the future. They also put us in  contact with a <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies">patent attorney</a> from Venner Shipley to further discuss the matter.
 <br /><br />
 <div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies"> More information </a></div>
@@ Line 512: / Line 533: @@
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="venner sup">
 <img class="cog19" src="https://static.igem.org/mediawiki/2016/9/9e/T--Manchester--cogwheelyellow.png"><img>
@@ Line 518: / Line 539: @@
 <div class="vennerinfo">
-We met with Matthew Handley a patent attorney to discuss whether our project was suitable for patenting. We discussed whether it would be realistic that we would be able to protect our project based on the current amount of information we had already disclosed to the public domain.
+After our meeting with the <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies">IP lawyer</a>, we were directed to speak to Matthew Handley, a patent attorney of Venner Shipley. We deliberated whether it would be realistic to patent our project based on the information we have already disclosed to the public domain.
 <br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies"> More information </a></div>
@@ Line 525: / Line 546: @@
-<div style="width: 100%; height:220px ">
+<div style="width: 100%; height:270px ">
 <div class="scram sup">
-<img class="cog20" src="https://static.igem.org/mediawiki/2016/9/9e/T--Manchester--cogwheelyellow.png"><img>
+<img class="cog20" src="https://static.igem.org/mediawiki/2016/7/71/T--Manchester--cogwheelorange.png"><img>
 </div>
 <div class="scraminfo">
-We talked with Mr Wojcik who works at Scram Systems in the US, he told us about how their products function and how the demands of the law in America have shaped the needs of law enforcement with regards to alcohol consumption. He describes the factors behind demand for a product like our AlcoPatch and whether it would be wanted by American companies.
+We spoke to Mark Wojcik, the Chief Technology Officer and the Vice President of Engineering of SCRAM Systems, a US-based ethanol <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Industries">biosensor company</a>. He informed us about how their devices function, and how American policies have shaped the needs of law enforcement with regards to alcohol consumption. He educated us on the factors behind the demand for a product like our AlcoPatch and the <a href="https://2016.igem.org/Team:Manchester/Model">marketability</a> of our product in the US.
 <br /><br />
-<div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies"> More information </a></div>
+<div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Industries"> More information </a></div>
 </div>
 </div>
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="brightside sup">
 <img class="cog21" src="https://static.igem.org/mediawiki/2016/7/71/T--Manchester--cogwheelorange.png"><img>
@@ Line 544: / Line 565: @@
 <div class="brightsideinfo">
-We met with Carley one of the owners of the family run business Brightside Brewery. With her we discussed whether breweries in the UK would have a use for our AlcoPatch and how the patch could offer benefits and avoid certain unfortunate situations with patrons.
+We met with Carley Freidrich, one of the owners of the family-run business Brightside Brewery. She offered her views on how <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Outreach">students</a> may perceive the AlcoPatch and highlighted the possible applications of our patch in the <a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies">National Health Service</a>.  It was brought to attention that breweries in the UK would have no use for our AlcoPatch. However, she suggested that bars and pubs may be interested in our product.
 <br /><br />
 <div style="text-align: right;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Industries"> More information </a></div>
@@ Line 551: / Line 572: @@
-<div style="width: 100%; height:200px ">
+<div style="width: 100%; height:270px ">
 <div class="fasd sup">
 <img class="cog22" src="https://static.igem.org/mediawiki/2016/9/9e/T--Manchester--cogwheelyellow.png"><img>
@@ Line 557: / Line 578: @@
 <div class="fasdinfo">
-We spoke with Dr.Mukherjee about our project and our AlcoPatch and he told us how relevant our product would be for his practice in treatment of fetal alcohol syndrome.
+We had a phone interview with Dr. Mukherjee, the Director of the National Clinic for Fetal Alcohol Spectrum Disorders (FASD). We discussed the relevance of the AlcoPatch with reference to his area of work, Fetal Alcohol Syndrome. It was concluded that his patients will not benefit from a product as such.
 <br /><br />
 <div style="text-align: left;"><a href="https://2016.igem.org/Team:Manchester/Human_Practices/Professional_Bodies"> More information </a></div>
@@ Line 563: / Line 584: @@
 </div>
+<div class="nav80">
+<div class="floatleft1 project1">
+<a class="projectlink" href="https://2016.igem.org/Team:Manchester"><< Main Page</a>
+</div>
+<div  class="floatright2 project1">
+<a style="z-index:1000" class="projectlink" href="#top">Top ^</a>
 </div>
+</div>
+</div>
 </body>

Difference between revisions of "Team:Manchester/Human Practices"